HF Acquisition Co LLC has recalled 9 boxes of Glycopyrrolate Injection (0.2mg/mL, 1mL vials) because the product labels may be incorrect. This medication is an injectable drug typically used in clinical settings to reduce secretions or treat stomach ulcers. No incidents or injuries have been reported, but the manufacturer initiated the recall after discovering the labeling error.
A label mix-up creates a risk that the wrong medication or an incorrect dosage could be administered to a patient. Because this is an injectable drug, an administration error could result in serious health complications depending on the medication actually contained in the vial.
Distributed in boxes of 25 vials.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.